Itanapraced

N/A

Report date: 2022/11/25 17:01:10
NME

Base Information

Drug NameItanapraced
Drug Alias NameCSP-1103CHF-5074
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItaly
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChiesi Farmaceutici SPA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCerespir IncorporatedChiesi Farmaceutici SPA
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A